ד"ר רקפת צ'רנינסקי


 
טלפון משרד: 02-6776140
פקס: 02-6447919
אימייל: [email protected]
תחום מחקר: פיתוח תרופתי
 
Synopsis
My activity within Oral Medicine focuses on disease processes of the oral mucosa; mainly oral cancer and precancer related conditions. The aims of my research are to understand oral carcinogenesis at the molecular and clinical levels and to explore the epidemiology of the disease in order to develop better tools for prevention of oral cancer, detection of early lesions and advance novel treatment and prophylactic options.

The studies are in an active collaboration with researchers from the US and with leading scientists in the Hebrew University. Students for DMD, MSc, PhD as well as Oral Medicine residents doing their basic science project are part of my research teams.Future research plans
Future research includes continuing basic ,translational and clinical research of oral carcinogenesis .These studies will improve our ability to understand and treat patient with oral mucosal diseases in general and in particular with premalignant conditions.

מלגות ופרסים

  • Israel Cancer Association: "Efficacy evaluation of a novel sirolimus local oral slow release delivery system on oral premalignancy as chemoprevention treatment". Rakefet Czerninski & Michael Friedman

    2015

  • Dr. Izador I. Cabakoff Research Endowment Fund: "Analysis of Protein S expression in Head and Neck Carcinoma". Rakefet Czerninski & Tal Burshtein –Cohen

    2012

  • Israel Cancer Research Fund (ICRF)." Development & Pharmacokinetic

    2011

  • Salivary Vs. blood levels of sirolimus (mTOR inhibitor) in treated patients - as a base for a novel local chemoprevention strategy and treatment of oral cancer

    2010

  • Joint Research grant of the Hebrew University Hadassah School of Dental

    2010

  • The first Procter and Gamble Award for Oral Care Innovation and Technologies

    2010

  • "Best poster award" at the International Academy of Oral Oncology Congress.Toronto, Canada

    2009